The Common Mistake of Ignoring Key Nutrient Levels Are Your Medications Making Things Worse
That step up came with the FDA approval of a new GLP-1 receptor agonist called semaglutide, best known as a weekly injection to treat type 2 diabetes that is sold under the brand name Ozempic
Before you and your care team add GLP-1s, heres what experts say you should think about: You Might Finally Be Able to Get Help for Your Other Health Conditions Unfortunately, many people with bipolar disorder meet the on-label criteria for GLP-1s like obesity or type 2 diabetes yet are not being treated, says McIntyre
Lightheadedness has been reported occasionally, potentially related to the vasodilatory effects of some components
It is common, usually manageable, and once you know what these drugs do, almost never mysterious
Approved products arrive as prefilled, single-dose pens with a manufacturer name on the label: Ozempic, Wegovy, or Rybelsus for semaglutide, Mounjaro or Zepbound for tirzepatide, and Saxenda or Victoza for liraglutide